Tevogen Bio Holdings (FRA:G28) Scaled Net Operating Assets : -1.63 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tevogen Bio Holdings's operating assets for the quarter that ended in Sep. 2024 was €1.76 Mil. Tevogen Bio Holdings's operating liabilities for the quarter that ended in Sep. 2024 was €6.77 Mil. Tevogen Bio Holdings's Total Assets for the quarter that ended in Jun. 2024 was €3.08 Mil. Therefore, Tevogen Bio Holdings's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was -1.63.

Tevogen Bio Holdings Scaled Net Operating Assets Historical Data

The historical data trend for Tevogen Bio Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Scaled Net Operating Assets Chart

Tevogen Bio Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Scaled Net Operating Assets

-0.02

47.63

Tevogen Bio Holdings Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial					-	-	-0.30	-2.03	-1.63

Competitive Comparison of Tevogen Bio Holdings's Scaled Net Operating Assets

For the Biotechnology subindustry, Tevogen Bio Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tevogen Bio Holdings's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tevogen Bio Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Tevogen Bio Holdings's Scaled Net Operating Assets falls into.

Tevogen Bio Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tevogen Bio Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(15.615	-	14.764)	/	337.138
=	0.00

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	15.623	-	0.008
=	15.615

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	16.261	-	0	-	1.497
=	14.764

Tevogen Bio Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(1.764	-	6.77)	/	3.075
=	-1.63

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.864	-	2.1
=	1.764

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	9.442	-	0.039	-	2.633
=	6.77

Tevogen Bio Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Tevogen Bio Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

TVGN:USA

Address

15 Independence Boulevard, Warren, NJ, USA, 07059

Website

https://www.tevogen.com

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

No Headlines